Inventor · disambiguated record
Paula J. Bates
Also filed as: BATES PAULA J
18 granted patents·14 pending applications·142 citations·filing 2000–2022
93Inventor score
Files withUNIV LOUISVILLE RES FOUND INC10BATES PAULA J7ANTISOMA RES LTD4UNIV LOUISVILLE RES FOUND3HAMMOND GERALD B2
Top patents by PatentIndex Score
32 records- 0194US8029784B2Method for the diagnosis and prognosis of malignant diseasesUNIV LOUISVILLE RES FOUND·Filed 2008·Granted Oct 4, 2011·13 cites·7 claims
- 0290US7541150B2Method for the diagnosis and prognosis of malignant diseasesUNIV LOUISVILLE RES FOUND·Filed 2002·Granted Jun 2, 2009·37 cites·34 claims
- 0390US7357928B2Method for the diagnosis and prognosis of malignant diseasesUNIV LOUISVILLE RES FOUND·Filed 2003·Granted Apr 15, 2008·28 cites·21 claims
- 0489US9452219B2Anti-nucleolin agent-conjugated nanoparticlesBATES PAULA J·Filed 2012·Granted Sep 27, 2016·8 cites·20 claims
- 0589US8586717B2Method for the diagnosis and prognosis of malignant diseasesBATES PAULA J·Filed 2011·Granted Nov 19, 2013·6 cites·19 claims
- 0689US7314926B1Antiproliferative activity of g-rich oligonucleotides and method of using same to bind to nucleolinANTISOMA RES LTD·Filed 2000·Granted Jan 1, 2008·27 cites·8 claims
- 0783US7960540B2Antiproliferative activity of G-rich oligonucleotides and method of using same to bind to nucleolinADVANCED CANCER THERAPEUTICS LLC·Filed 2007·Granted Jun 14, 2011·3 cites·11 claims
- 0880US8114850B2Antiproliferative activity of G-rich oligonucleotides and method of using same to bind to nucleolinTRENT JOHN O·Filed 2007·Granted Feb 14, 2012·5 cites·20 claims
- 0979US11344633B2Anti-nucleolin agent-conjugated nanoparticlesUNIV LOUISVILLE RES FOUND INC·Filed 2016·Granted May 31, 2022·1 cites·18 claims
- 1079US8207381B2Therapeutic compoundsHAMMOND GERALD B·Filed 2008·Granted Jun 26, 2012·4 cites·36 claims
- 1178US8703829B2Therapeutic compoundsHAMMOND GERALD B·Filed 2012·Granted Apr 22, 2014·4 cites·19 claims
- 1275US10857237B2Anti-nucleolin agent-conjugated nanoparticles as radio-sensitizers and MRI and/or X-ray contrast agentsUNIV LOUISVILLE RES FOUND INC·Filed 2016·Granted Dec 8, 2020·1 cites·20 claims
- 1372US2022265867A1Anti-nucleolin agent-conjugated nanoparticlesUNIV LOUISVILLE RES FOUND INC·Filed 2022·Application pending·0 cites
- 1470US9737493B2Compositions and methods for modulating DNMT1 inhibitor activityUNIV LOUISVILLE RES FOUND INC·Filed 2013·Granted Aug 22, 2017·1 cites·19 claims
- 1569US8648051B2Antiproliferative activity of G-rich oligonucleotides and method of using same to bind to nucleolinMILLER DONALD M·Filed 2004·Granted Feb 11, 2014·3 cites·10 claims
- 1667US2014220013A1Method for the diagnosis and prognosis of malignant diseasesBATES PAULA J·Filed 2013·Application pending·0 cites
- 1760US9383364B2Predictive marker of DNMT1 inhibitor therapeutic efficacy and methods of using the markerBATES PAULA J·Filed 2012·Granted Jul 5, 2016·1 cites·14 claims
- 1858US2008318890A1Antiproliferative activity of G-rich oligonucleotides and method of using same to bind to nucleolinANTISOMA RES LTD·Filed 2007·Application pending·0 cites
- 1958US2011178161A1Antiproliferative activity of G-rich oligonucleotides and method of using same to bind to nucleolinANTISOMA RES LTD·Filed 2007·Application pending·0 cites
- 2058US2011065121A1Method for the detection of apoptosisBATES PAULA J·Filed 2009·Application pending·0 cites
- 2157US2020390904A1Anti-nucleolin agent-conjugated nanoparticles as radio-sensitizers and mri and/or x-ray contrast agentsUNIV LOUISVILLE RES FOUND INC·Filed 2020·Application pending·0 cites
- 2254US2021299156A1Methods of inhibiting or treating coronavirus infection, and methods for delivering an anti-nucleolin agentUNIV LOUISVILLE RES FOUND INC·Filed 2021·Application pending·0 cites
- 2351US2023181769A1Anti-nucleolin agent-peg-conjugated nanoparticlesUNIV LOUISVILLE RES FOUND INC·Filed 2020·Application pending·0 cites
- 2451US2009226914A1Methods and products to target, capture and characterize stem cellsBATES PAULA J·Filed 2008·Application pending·0 cites
- 2550US2005187176A1Method for inhibiting NF-kappa B signaling and use to treat or prevent human diseasesFiled 2004·Application pending·0 cites
- 2649US2004132049A1Method for the detection of apoptosisFiled 2003·Application pending·0 cites
- 2747US11679098B2Methods for treating diseasesUNIV LOUISVILLE RES FOUND INC·Filed 2019·Granted Jun 20, 2023·0 cites·21 claims
- 2847US2008318889A1Antiproliferative activity of G-rich oligonucleotides and method of using same to bind to nucleolinANTISOMA RES LTD·Filed 2007·Application pending·0 cites
- 2943US9492428B2Compounds, compositions, pharmaceutical compositions, and methods of useUNIV LOUISVILLE RES FOUND INC·Filed 2012·Granted Nov 15, 2016·0 cites·26 claims
- 3042US2019192686A1Targeted nanodroplet emulsions for treating cancerTHE UNIV OF LOUISVILLE RESEARCH FOUNDATION·Filed 2017·Application pending·0 cites
- 3137US11208379B2Compounds, compositions, methods for treating diseases, and methods for preparing compoundsUNIV LOUISVILLE RES FOUND INC·Filed 2019·Granted Dec 28, 2021·0 cites·37 claims
- 3232US2013065227A1Methods of increasing macropinocytosis in cancer cellsBATES PAULA J·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Paula J. Bates files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →